Sweden· SE-20191129000034
Levosimendan Tillomed 2,5 mg/ml Koncentrat till infusionsvätska, lösning
A levosimendan product containing levosimendan, registered in Sweden by Tillomed Pharma GmbH. The same ATC class is registered in 14 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Levosimendan is registered in 14 of 19 countries.
Countries holding a registration under ATC C01CX08 (levosimendan), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 8 of them publish a price we can compare per daily dose
Levosimendan · ATC C01CX08
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Levosimendan
- Manufacturer
- Tillomed Pharma GmbH
- Country
- Sweden (SE)
- ATC code
- C01CX08
- ATC class
- Levosimendan
- Defined daily dose
- 11 mg, P
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20191129000034
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levosimendan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLEVOSIMENDAN FMKFARMAK INTERNATIONAL Sp.z.o.o., Varšava
- FinlandLevosimendan AltanAltan Pharma Ltd
- PolandLevosimendan AccordAccord Healthcare Polska Sp. z o.o.
- SwitzerlandLevosimendan Ideogen 12,5 mg/5 ml, Konzentrat zur Herstellung einer InfusionslösungIDEOGEN AG
- BelgiumLevosimendan Altan 2.5 mg/mlAltan Pharma
- NorwayLevosimendan KalceksAS Kalceks
- IcelandLevosimendan STADASTADA Arzneimittel AG
- IrelandLevosimendan 2.5 mg/ml concentrate for solution for infusionAS Kalceks
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Cordenova, Levosimendan Accord
- Belgium · Levosimendan Kabi, Levosimendan Kalceks
- Bulgaria · Левосимендан Калцекс, Симдакс
- Cyprus · Levosimendan Win Medica, Simdax
- Czechia · Levosimendan Fmk, Levosimendan Kalceks
- Germany · Levosimendan Accord, Levosimendan Altan
- Denmark · Levosimendan, Levosimendan Amdipharm
- Estonia · Levosimendan Auxilia, Levosimendan Kalceks
- Spain · Levosimendán Accord, Levosimendán Altan
- Finland · Levosimendan Amdipharm, Levosimendan Bioglan
- France · Levosimendan Accord, Levosimendan Altan
- Greece · Levosimendan Win Medica, Simdax
- Croatia · Levosimendan Alpha-Medical, Levosimendan Kalceks
- Hungary · Levosimendan Kalceks, Levosimendan Stada
- Ireland · Levosimendan Kalceks
- Iceland · Levosimendan Stada, Simdax
- Italy · Levosimendan Accord, Levosimendan Altan
- Lithuania · Levosimendan Kalceks
- Latvia · Levosimendan Kalceks
- Netherlands · Levosimendan Carinopharm, Levosimendan Kalceks
- Norway · Levosimendan Amdipharm, Levosimendan Bioglan
- Poland · Levosimendan Accord, Levosimendan Farmak
- Portugal · Levossimendano Accord, Levossimendano Altan
- Romania · Levatrop, Levosimendan
- Slovenia · Levosimendan Carinopharm, Levosimendan Kalceks
- Slovakia · Levosimendan Fmk, Levosimendan Kalceks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5ed07a8-b5e0-4c1f-a725-6113c6674ae3 GET /v1/drugs/d5ed07a8-b5e0-4c1f-a725-6113c6674ae3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20191129000034",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20191129000034",
"product_doc_link": "https://docetp.mpa.se/LMF/Levosimendan%20Tillomed%20concentrate%20for%20solution%20for%20infusion%20SmPC_09001bee82b6d456.pdf"
}See everything about levosimendan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.